Director-general of the National Agency for Food and Drug Administration And Control , Prof. Mojisola Adeyeye, disclosed this at a press briefing on Monday in Abuja.
This came days after Ghana became the first country to approve the vaccine, which is manufactured by the Serum Institute of India Pvt Ltd. Adeyeye said the vaccine was indicated for prevention of clinical malaria in children from five months to three years of age, adding that the storage temperature of the vaccine is 2-8 °C.
“The R21 Malaria vaccine is an Adjuvanted protein vaccine presented as a sterile solution. A dose which is 0.5ml is composed of R21 Malaria antigen 5µg and Matrix-M1 50µg as an adjuvant filled in a vial as ready to use liquid formulation for intramuscular injection. “The vaccine is indicated for prevention of clinical malaria in children from five months to 36 months of age. The storage temperature of the vaccine is 2-8 °C,” she said.
Education Education Latest News, Education Education Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: thecableng - 🏆 2. / 80 Read more »